Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30014974)

  • 1. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.
    Mao H; Bao T; Shen X; Li Q; Seluzicki C; Im EO; Mao JJ
    Eur J Cancer; 2018 Sep; 101():47-54. PubMed ID: 30014974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
    Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
    Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
    Bauml J; Chen L; Chen J; Boyer J; Kalos M; Li SQ; DeMichele A; Mao JJ
    Breast Cancer Res; 2015 Jun; 17(1):89. PubMed ID: 26126656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
    Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
    Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Chen J; Mao JJ
    Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
    Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
    BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
    Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
    J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Hong D; Bi L; Zhou J; Tong Y; Zhao Q; Chen J; Lu X
    Oncotarget; 2017 Jun; 8(25):40558-40567. PubMed ID: 28489562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
    Pedersini R; Monteverdi S; Mazziotti G; Amoroso V; Roca E; Maffezzoni F; Vassalli L; Rodella F; Formenti AM; Frara S; Maroldi R; Berruti A; Simoncini E; Giustina A
    Bone; 2017 Apr; 97():147-152. PubMed ID: 28104509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
    Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
    Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
    Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
    Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
    Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
    Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
    Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
    Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
    Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
    Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
    Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with chronic pain: perceptions of breast cancer survivors.
    Bao T; Seidman A; Li Q; Seluzicki C; Blinder V; Meghani SH; Farrar JT; Mao JJ
    Breast Cancer Res Treat; 2018 May; 169(1):133-140. PubMed ID: 29350307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
    Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
    Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
    Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
    J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.